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INTRODUCTION
 Gastrointestinal stromal tumor (GIST) is a rare tumor arising 
from the mesenchymal tissue of the sub-epithelial mucosal surface 
of the gastrointestinal tract.1 It is mainly located in the stomach and 
proximal intestine, but can be seen in other parts of the gastrointes-
tinal tract. It is characterized by expression of CD117 which is a part 
of the C-kit proto-oncogene product (KIT) transmembrane recep-
tor tyrosine kinase in more than 80% of cases.2 Some cases express 
a mutation in PDGFRA (platelet-derived growth factor receptor, 
alpha polypeptide). GIST has the potential to become a malig-
nant tumor, which can metastasize to the liver and peritoneum.3-5
 Multiple endocrine neoplasia type 1 (MEN1) syndrome is an 
autosomal dominant (AD) disorder, characterized by inactivation 
of the Menin gene, a tumor suppressor located on the long arm of 
chromosome 13 (13q11).6 MEN1 syndrome is associated with pi-
tuitary, parathyroid, and pancreatic islet tumors.7,8 Some non-en-
docrine benign tumors also are associated with MEN1 syndrome, 
such as facial angiofibromas, lipomas, meningioma, and leiomyo-
ma.9 The association between GIST tumors and MEN1 syndrome, 
however, is unclear. To our knowledge, only five cases had re-
ported GIST tumors in association with MEN1 syndrome.10-12
CASE REPORT
 A 60-year-old male had a 6 cm mass of the pancreas body and tail 
discovered on a computed tomography (CT) scan of the abdomen 
which was done to evaluate recurrent hypercalcemia nephrolithia-
sis. The diagnosis of a well-differentiated neuroendocrine pancre-
atic tumor was made by fine needle aspiration (FNA). Following 
staging, surgical resection was performed (T3N0M0). In addition 
to that, another 2 cm tumor was attached to the distal body and 
along the greater curvature of the stomach. Pathology of this new 
tumor revealed a GIST tumor with positive C-kit proto-oncogene 
product (CD117) and negative S-100 calcium binding protein.
 At the time of surgery, the patient’s serum calcium was el-
evated up to 11.4 mg/dl. His parathyroid hormone was 53 pg/
ml and spot urine calcium was 28.4 mg/dl. Pituitary function 
testing, including levels of follicle-stimulating hormone, thy-
roid-stimulating hormone, prolactin, insulin-like growth factor, 
and adrenocorticotropic hormone were within normal range 
with the exception of a mild elevation of luteinizing hormone. 
A Sestamibi scan revealed persistent radiotracer uptake in the 
region of the right inferior parathyroid gland thought to be con-
sistent with a parathyroid adenoma. Magnetic resonance im-
aging (MRI) of the brain revealed a 0.5 cm pituitary adenoma.
 The patient underwent parathyroidectomy. As a result, 
the diagnosis of MEN1 was made clinically, although a ge-
netic test for MEN1 was negative. As the patient was recover-
ing, another CT scan of the abdomen was taken to investigate 
the reason of his persistent hematuria and nephrolithiasis. This 
scan revealed a new 1.9 cm, peripherally enhancing mass on 
the ventral side of the pancreas head. Endoscopic ultrasound 
(EUS) revealed another neuroendocrine tumor of the pan-
creas. At that point, the patient underwent exploratory lapa-
rotomy for resection of this neuroendocrine tumor with no 
residual metastasis. He recovered well after the surgery. His fol-
lowing labs revealed normal calcium as well as vitamin D level. 
DISCUSSION
 This case of MEN1 syndrome was associated with GIST of the 
stomach and found incidentally during a surgical removal of a 
pancreatic neuroendocrine tumor. GIST is the most common non-
epithelial tumor of the gastrointestinal tract and may become 
malignant in 1% of cases.3-5,13,14 Usually GIST tumors are asymp-
tomatic and discovered incidentally on imaging or endoscopy. 
However, some patients may experience non-specific symptoms 
such as early satiety, bloating, and ulceration with bleeding.1
 Diagnosis of MEN1 is usually estab-
lished by one of the following three criteria: 9,15
 1. Having two or more of the classical primary three tu-
mors: parathyroid gland, anterior pituitary, or enter-pancre-
atic cell (such as gastrinoma, insulinoma, vasoactive intestinal 
polypeptide secreting tumor, and non-hormone secreting).
 2. Determination of DNA genetic mutation in an indi-
vidual who does not have clinical or biochemical features.
 3. Having a family member with MEN1 syndrome.
 DNA testing is completed to identify any menin mutation at 
chromosome 11q13 which is found in up to 90% of the cases.7,9 
Usually DNA testing is offered to any index patient with clini-
cal MEN1 (two or more primary MEN1 tumor types), all first-
degree relatives of known MEN1 mutation carriers, and to 
individuals with suspicious or atypical MEN1 (e.g., multiple 
parathyroid adenomas, gastrinoma, or multiple pancreatic neu-
roendocrine tumors).7 In our case, the diagnosis was based on 
the clinical findings of the classical tumors of MEN1 syndrome. 
 In addition to the classical findings, non-endocrine tumors have 
been identified in some MEN1 cases such as carcinoid tumors, 
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adrenocortical tumors, meningioma, facial angio-fibromas, and 
lipomas.9 The MEN1 gene was suggested to act as a recessive tu-
mor suppressor gene due to high rate of heterozygosity which was 
detected in the primary tumors as well as non-classical tumors.8, 16
 Few previous case reports detected GIST in association 
with MEN1 syndrome. None detected any loss of hetero-
zygosity (LOH).10-12 Another case report was unable to de-
tect any LOH in 11q13 area in a MEN1 syndrome associated 
with GIST using the PYGM microsatellite polymorphism 
and a MEN-1 intragenic polymorphism localized in exon 
9 (D418D).17 Different mechanisms were suggested to ex-
plain this association: (1) an unknown independent mecha-
nism or (2) a loss of the genes located closely to 11q13 gene. 
 The etiology of our patient’s hypercalcemia was likely second-
ary to hyperparathyroidism as his calcium level trended down 
after parathyroidectomy. Hypercalcemia has been associated 
with GIST tumor.18 The etiology was thought to be due to PTH-
related peptide production. However, one recent case reported 
hypercalcemia associated with GIST tumor in the setting of sup-
pressed PTH and Pro PTH but elevated 1,25(OH)2 vitamin D level.
CONCLUSION
 We reported another case in which MEN1 was associated 
with GIST. Yet, no evidence-based data support or explain 
the clinical association between GIST and MEN1 syndrome. 
However, this association should be considered when a GI tu-
mor is associated with clinical features of MEN1 syndrome. 
Hypercalcemia likely was secondary to hyperparathyroid-
ism.  Although GIST induced hypercalcemia caused by con-
verting vitamin D to its active form also should be considered.
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